Patent · US Active

Compounds as cannabinoid receptor ligands

US8058293B2 · kind B2 · utility

9Cited by

11References

13Claims

0Family size

Assignee

Abbott Laboratories · US

Inventors

Teodozyj Kolasa · Lake Villa, US
Jennifer M. Frost · Grayslake, US
Meena Patel · Libertyville, US
Steven P. Latshaw · Round Lake, US
Arturo Medrano · Grayslake, US
Xueqing Wang · Evanston, US
Karin Rose Marie Tietje · Mundelein, US
Sridhar Peddi · Grayslake, US
William A. Carroll · Evanston, US

Key dates

Filing date	Mar 11, 2009
Grant date	Nov 15, 2011
Priority date	—
Expiry date	May 5, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compounds of formula (I)wherein R1, R2, R3, R25a, R26a, X, and n are as defined in the specification. Pharmaceutical compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and pharmaceutical compositions are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.